sitem-insel AG

October 21, 2019, 13:00 - 14:30

Development of LV gene therapy or gene editing for immune disorders - lessons from XLA
Prof. David Rawlings
Department of Pediatrics
University of Washington

David J. Rawlings, MD, is chief in the Division of Immunology, overseeing the immunodeficiency clinic at Seattle Childrens Hospital. He is also director of the Center for Immunity and Immunotherapies leading the immunology research programs at Seattle Childrens Research Institute. Dr. Rawlings is professor of pediatrics and adjunct professor in the Department of Immunology at the University of Washington School of Medicine.

https://www.seattlechildrens.org/directory/david-j-rawlings/